For instance, the elevated expression of TRPM2 is correlated with breast, lung and prostate cancer cell survival [59], whereas TRPV6 overexpression has been reported in prostate cancer [60] as well as incriminated in breast cancer metastasis [61,62]. This evidence concerns the gene TRPV6 and prostate carcinoma.